Envista Holdings Corp. (NVST): Price and Financial Metrics
NVST Price/Volume Stats
| Current price | $32.52 | 52-week high | $43.94 |
| Prev. close | $31.89 | 52-week low | $31.20 |
| Day low | $31.67 | Volume | 1,481,145 |
| Day high | $32.53 | Avg. volume | 1,965,470 |
| 50-day MA | $36.72 | Dividend yield | N/A |
| 200-day MA | $36.15 | Market Cap | 5.32B |
NVST Stock Price Chart Interactive Chart >
NVST POWR Grades
- Value is the dimension where NVST ranks best; there it ranks ahead of 77.45% of US stocks.
- The strongest trend for NVST is in Growth, which has been heading down over the past 179 days.
- NVST ranks lowest in Sentiment; there it ranks in the 14th percentile.
NVST Stock Summary
- ENVISTA HOLDINGS CORP's stock had its IPO on September 18, 2019, making it an older stock than merely 18.33% of US equities in our set.
- The price/operating cash flow metric for ENVISTA HOLDINGS CORP is higher than 85.64% of stocks in our set with a positive cash flow.
- In terms of volatility of its share price, NVST is more volatile than merely 12.37% of stocks we're observing.
- Stocks that are quantitatively similar to NVST, based on their financial statements, market capitalization, and price volatility, are NSYS, FONR, NVT, VSTO, and HAYW.
- NVST's SEC filings can be seen here. And to visit ENVISTA HOLDINGS CORP's official web site, go to www.envistaco.com.
NVST Valuation Summary
- In comparison to the median Healthcare stock, NVST's EV/EBIT ratio is 79.17% higher, now standing at 21.5.
- NVST's price/sales ratio has moved up 0.7 over the prior 45 months.
Below are key valuation metrics over time for NVST.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| NVST | 2023-05-23 | 2.2 | 1.3 | 26.3 | 21.5 |
| NVST | 2023-05-22 | 2.3 | 1.4 | 27.6 | 22.4 |
| NVST | 2023-05-19 | 2.3 | 1.4 | 27.3 | 22.2 |
| NVST | 2023-05-18 | 2.3 | 1.4 | 27.5 | 22.4 |
| NVST | 2023-05-17 | 2.2 | 1.3 | 26.8 | 21.9 |
| NVST | 2023-05-16 | 2.2 | 1.3 | 26.4 | 21.6 |
NVST's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- NVST has a Quality Grade of C, ranking ahead of 69.17% of graded US stocks.
- NVST's asset turnover comes in at 0.429 -- ranking 110th of 186 Medical Equipment stocks.
- 500 - Internal server error
The table below shows NVST's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-07-02 | 0.429 | 0.545 | 0.200 |
| 2021-04-02 | 0.369 | 0.523 | 0.079 |
| 2020-12-31 | 0.346 | 0.507 | 0.014 |
| 2020-10-02 | 0.354 | 0.511 | 0.006 |
| 2020-07-03 | 0.364 | 0.518 | 0.011 |
| 2019-12-31 | 0.459 | 0.550 | 0.209 |
Envista Holdings Corp. (NVST) Company Bio
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The firm operates through the following segments; Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018 and is headquartered in Brea, CA.
Latest NVST News From Around the Web
Below are the latest news stories about ENVISTA HOLDINGS CORP that investors may wish to consider to help them evaluate NVST as an investment opportunity.
Envista Announces Participation in Stifel 2023 Jaws & Paws ConferenceEnvista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Stifel 2023 Jaws & Paws Conference on Wednesday, May 31, 2023, from 8:00 – 8:30 AM EDT in New York, New York. |
Envista (NVST) Q1 Earnings Miss Estimates, Margins DownWeakness in China and Russia and lower demand for large capital equipment hurts Envista's (NVST) Q1 revenues. |
Q1 2023 Envista Holdings Corp Earnings CallQ1 2023 Envista Holdings Corp Earnings Call |
Envista (NVST) Q1 Earnings and Revenues Miss EstimatesEnvista (NVST) delivered earnings and revenue surprises of -7.32% and 0.59%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |
Envista Reports First Quarter 2023 EarningsEnvista Holdings Corporation (NYSE: NVST) today announced results for the first quarter 2023. |
NVST Price Returns
| 1-mo | -13.21% |
| 3-mo | -18.07% |
| 6-mo | -6.61% |
| 1-year | -22.59% |
| 3-year | 51.61% |
| 5-year | N/A |
| YTD | -3.42% |
| 2022 | -25.28% |
| 2021 | 33.59% |
| 2020 | 13.80% |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...